118 related articles for article (PubMed ID: 2458074)
1. [A radioimmunometric assay for circulating tumor-associated glycoprotein (TAG-72) using the antigen determinant CA 72-4].
Ohuchi N; Takahashi K; Matoba N; Mori S
Gan To Kagaku Ryoho; 1988 Sep; 15(9):2761-6. PubMed ID: 2458074
[TBL] [Abstract][Full Text] [Related]
2. [CA 15-3 is present as a novel tumor marker in the sera of patients with breast cancer and other malignancies].
Gang Y; Adachi I; Ohkura H; Yamamoto H; Mizuguchi Y; Abe K
Gan To Kagaku Ryoho; 1985 Dec; 12(12):2379-86. PubMed ID: 3865634
[TBL] [Abstract][Full Text] [Related]
3. [Levels of circulating tumor-associated glycoprotein (TAG-72) in patients with carcinoma using a novel tumor marker, CA 72-4].
Ohuchi N; Matoba N; Taira Y; Takahashi K; Sakai N; Sato K; Fujita N; Mochizuki F; Nishihira T; Mori S
Gan To Kagaku Ryoho; 1988 Sep; 15(9):2767-72. PubMed ID: 3166366
[TBL] [Abstract][Full Text] [Related]
4. Serological mapping of the TAG-72 tumor-associated antigen using 19 distinct monoclonal antibodies.
Kuroki M; Fernsten PD; Wunderlich D; Colcher D; Simpson JF; Poole DJ; Schlom J
Cancer Res; 1990 Aug; 50(16):4872-9. PubMed ID: 1696162
[TBL] [Abstract][Full Text] [Related]
5. Serum levels and biochemical characteristics of cancer-associated antigen CA-549, a circulating breast cancer marker.
Bray KR; Koda JE; Gaur PK
Cancer Res; 1987 Nov; 47(22):5853-60. PubMed ID: 2444335
[TBL] [Abstract][Full Text] [Related]
6. [CA 125 (cancer antigen 125), a new tumor associated antigen recognized by monoclonal antibody].
Suzuki H; Teshima K; Noda K
Gan To Kagaku Ryoho; 1984 Dec; 11(12 Pt 2):2719-23. PubMed ID: 6594978
[TBL] [Abstract][Full Text] [Related]
7. [Evaluation of CA 19-9 radioimmunoassay].
Toya D; Takemori Y; Kidani H; Yoneshima M; Hattori N; Sawabu N
Gan To Kagaku Ryoho; 1984 Mar; 11(3):509-14. PubMed ID: 6584087
[TBL] [Abstract][Full Text] [Related]
8. Detection of circulating gastric carcinoma-associated antigen MG7-Ag in human sera using an established single determinant immuno-polymerase chain reaction technique.
Ren J; Chen Z; Juan SJ; Yong XY; Pan BR; Fan DM
Cancer; 2000 Jan; 88(2):280-5. PubMed ID: 10640958
[TBL] [Abstract][Full Text] [Related]
9. A comparative study of mucin-like carcinoma-associated antigen (MCA), CA 125, CA 19-9 and CEA in patients with ovarian cancer.
Koelbl H; Schieder K; Neunteufel W; Bieglmayer C
Neoplasma; 1989; 36(4):473-8. PubMed ID: 2770933
[TBL] [Abstract][Full Text] [Related]
10. Comparison of serum assays for TAG-72, CA19-9 and CEA in gastrointestinal carcinoma patients.
Ohuchi N; Takahashi K; Matoba N; Sato T; Taira Y; Sakai N; Masuda M; Mori S
Jpn J Clin Oncol; 1989 Sep; 19(3):242-8. PubMed ID: 2810823
[TBL] [Abstract][Full Text] [Related]
11. Selection of a monoclonal antibody reactive with a high-molecular-weight glycoprotein circulating in the body fluid of gastrointestinal cancer patients.
Sakurai Y; Hirohashi S; Shimosato Y; Kodaira S; Abe O
Cancer Res; 1988 Jul; 48(14):4053-8. PubMed ID: 2454734
[TBL] [Abstract][Full Text] [Related]
12. Generation and characterization of B72.3 second generation monoclonal antibodies reactive with the tumor-associated glycoprotein 72 antigen.
Muraro R; Kuroki M; Wunderlich D; Poole DJ; Colcher D; Thor A; Greiner JW; Simpson JF; Molinolo A; Noguchi P
Cancer Res; 1988 Aug; 48(16):4588-96. PubMed ID: 3396010
[TBL] [Abstract][Full Text] [Related]
13. [Clinical evaluation of a new tumor marker, CA 15-3, in breast cancer; a comparative study with CEA].
Komuro K; Watanabe K; Ishida T; Sakurai M; Amano R; Hagiwara H; Hara Y; Hanzawa T; Itsubo K
Gan To Kagaku Ryoho; 1986 Oct; 13(11):3145-9. PubMed ID: 3465273
[TBL] [Abstract][Full Text] [Related]
14. [CA 19-9 in early cancers of the bronchi. Comparison with the carcinoembryogenic antigen].
Vindimian M; Lafitte JJ; Wattre P
Biomed Pharmacother; 1987; 41(4):191-5. PubMed ID: 3476162
[TBL] [Abstract][Full Text] [Related]
15. Correlation between tumor-associated glycoprotein 72 mucin levels in tumor and serum of colorectal patients as measured by the quantitative CA 72-4 immunoassay.
Guadagni F; Roselli M; Cosimelli M; Spila A; Cavaliere F; Tedesco M; Arcuri R; Abbolito MR; Casale V; Pericoli MN; Vecchione A; Casciani CU; Greiner JW; Schlom J
Cancer Res; 1996 Nov; 56(22):5293-8. PubMed ID: 8912871
[TBL] [Abstract][Full Text] [Related]
16. Tumorigenicity in athymic mice of the human colon carcinoma cell line SW1116 expressing the tumor-associated antigenic determinant CA 19-9.
Klug TL; Salzman S; Quinn A; Melincoff GA; Sedmak DD; Tubbs RR; Zurawski VR
Cancer Res; 1984 Nov; 44(11):5212-8. PubMed ID: 6207914
[TBL] [Abstract][Full Text] [Related]
17. Clinical experience with the tumor marker Ca 19-9 in an unselected group of more than 300 tumor patients.
Souchon R; Koppenhagen K; Souchon MF; Matthes M; Boese-Landgraf J; Fitzner R; Baer U
Cancer Detect Prev; 1985; 8(1-2):101-9. PubMed ID: 3864534
[TBL] [Abstract][Full Text] [Related]
18. CA125 antigen levels in obstetric and gynecologic patients.
Niloff JM; Knapp RC; Schaetzl E; Reynolds C; Bast RC
Obstet Gynecol; 1984 Nov; 64(5):703-7. PubMed ID: 6208522
[TBL] [Abstract][Full Text] [Related]
19. [Serum carbohydrate 19-9 Tm and bronchial cancer. Comparative study with another tumor marker, carcinoembryonic antigen].
Bisset JP; Kleisbauer JP; Roux F; Treffot MJ
Pathol Biol (Paris); 1985 Jun; 33(6):672-6. PubMed ID: 3900886
[TBL] [Abstract][Full Text] [Related]
20. A radioimmunoassay using a monoclonal antibody to monitor the course of epithelial ovarian cancer.
Bast RC; Klug TL; St John E; Jenison E; Niloff JM; Lazarus H; Berkowitz RS; Leavitt T; Griffiths CT; Parker L; Zurawski VR; Knapp RC
N Engl J Med; 1983 Oct; 309(15):883-7. PubMed ID: 6310399
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
